Therapeutic efficacy of SJA6017, a calpain inhibitor, in rat spinal cord injury

Journal of Clinical Neuroscience

Volumn 15, Issue 10, 2008, Pages 1130-1136

  Akdemir, Osman ^a   Uçankale, Murat ^a   Karaoǧlan, Alper ^a   Barut, Şeref ^a   Saǧmanligil, Ayhan ^a   Bilguvar, Kaya ^b   Çirakoǧlu, Beyazit ^b   Şahan, Elife ^a   Çolak, Ahmet ^c  

^a ISTANBUL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c MALTEPE UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Calpains; Programmed cell death; Spinal cord injury

Indexed keywords

CALPASTATIN; SJA 6017; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLEEDING; CELL DEATH; CONTROLLED STUDY; DRUG EFFICACY; EDEMA; MICROSCOPY; NECROSIS; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; THROMBOSIS;

ANIMALS; APOPTOSIS; CALPAIN; DIPEPTIDES; ENZYME INHIBITORS; IN SITU NICK-END LABELING; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; SPINAL CORD; SPINAL CORD INJURIES; TREATMENT OUTCOME;

EID: 50249159454     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2007.08.011     Document Type: Article

References (43)

1. Beattie M.S., Farooqui A.A., and Bresnahan J.C. Review of current evidence for apoptosis after spinal cord injury. J Neurotrauma 17 (2000) 915-925
2. Bresnahan J.C., Schuman S.L., and Beattie M.S. Evidence for apoptosis of oligodendroglia in long tracts undergoing Wallerian degeneration after spinal cord injury (SCI) in monkeys. Soc Neurosci Abstr 22 (1996) 1185
3. Casha S., Yu W.R., and Fehlings M.G. Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 103 (2001) 203-218
4. Crowe M.J., Bresnahan J.C., Shuman S.L., et al. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 3 (1997) 73-76
5. Keane R.W., Kraydieh S., Lotocki G., et al. Apoptotic and anti-apoptotic mechanisms following spinal cord injury. J Neuropathol Exp Neurol 60 (2001) 422-429
6. Lou J., Lenke L.G., Ludwig F.J., et al. Apoptosis as a mechanism of neuronal cell death following acute experimental spinal cord injury. Spinal Cord 36 (1998) 683-690
7. Lu J., Ashwell K.W., and Waite P. Advances in secondary spinal cord injury: role of apoptosis. Spine 25 (2000) 1859-1866
8. Barut S., Unlu Y.A., Karaoglan A., et al. The neuroprotective effects of z-DEVD.fmk, a caspase-3 inhibitor, on traumatic spinal cord injury in rats. Surg Neurol 64 (2005) 213-220 discussion 220
9. Colak A., Karaoglan A., Barut S., et al. Neuroprotection and functional recovery after application of the caspase-9 inhibitor z-LEHD-fmk in a rat model of traumatic spinal cord injury. J Neurosurg Spine 2 (2005) 327-334
10. Emery E., Aldana P., Bunge M.B., et al. Apoptosis after traumatic human spinal cord injury. J Neurosurg 89 (1998) 911-920
11. Crocker S.J., Smith P.D., Jackson-Lewis V., et al. Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J Neurosci 23 (2003) 4081-4091
12. Raynaud F., and Marcilhac A. Implication of calpain in neuronal apoptosis. A possible regulation of Alzheimer's disease. FEBS J 273 (2006) 3437-3443
13. Tsuji T., Shimohama S., Kimura J., et al. m-Calpain (calcium-activated neutral proteinase) in Alzheimer's disease brains. Neurosci Lett 248 (1998) 109-112
14. Blomgren K., Hallin U., Andersson A.L., et al. Calpastatin is up-regulated in response to hypoxia and is a suicide substrate to calpain after neonatal cerebral hypoxia-ischemia. J Biol Chem 274 (1999) 14046-14052
15. Nakagawa T., Zhu H., Morishima N., et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β. Nature 403 (2000) 98-103
16. Ray S.K., Matzelle D.D., Wilford G.G., et al. Inhibition of calpain-mediated apoptosis by E-64 d-reduced immediate early gene (IEG) expression and reactive astrogliosis in the lesion and penumbra following spinal cord injury in rats. Brain Res 916 (2001) 115-126
17. Wootz H., Hansson I., Korhonen L., et al. XIAP decreases caspase-12 cleavage and calpain activity in spinal cord of ALS transgenic mice. Exp Cell Res 312 (2006) 1890-1898
18. Banik N.L., Shields D.C., Ray S., et al. Role of calpain in spinal cord injury: effects of calpain and free radical inhibitors. Ann NY Acad Sci 844 (1998) 131-137
19. Shields D.C., Schaecher K.E., Hogan E.L., et al. Calpain activity and expression increased in activated glial and inflammatory cells in penumbra of spinal cord injury lesion. J Neurosci Res 61 (2000) 146-150
20. Banik N.L., Hogan E.L., Powers J.M., et al. Degradation of cytoskeletal proteins in experimental spinal cord injury. Neurochem Res 7 (1982) 1465-1475
21. Du S., Rubin A., Klepper S., et al. Calcium influx and activation of calpain I mediate acute reactive gliosis in injured spinal cord. Exp Neurol 157 (1999) 96-105
22. Guroff A. A neutral, calcium-activated proteinase from the soluble fraction of rat brain. J Biol Chem 239 (1964) 149-155
23. 2+-accumulation in experimental spinal cord trauma. Brain Res 211 (1981) 476-479
24. Arataki S., Tomizawa K., Moriwaki A., et al. Calpain inhibitors prevent neuronal cell death and ameliorate motor disturbances after compression-induced spinal cord injury in rats. J Neurotrauma 22 (2005) 398-406
25. Ray S.K., Hogan E.L., and Banik N.L. Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors. Brain Res Rev 42 (2003) 169-185
26. Schumacher P.A., Siman R.G., and Fehlings M.G. Pretreatment with calpain inhibitor CEP-4143 inhibits calpain I activation and cytoskeletal degradation, improves neurological function, and enhances axonal survival after traumatic spinal cord injury. J Neurochem 74 (2000) 1646-1655
27. Zhang S.X., Bondada V., and Geddes J.W. Evaluation of conditions for calpain inhibition in the rat spinal cord: effective postinjury inhibition with intraspinal MDL28170 microinjection. J Neurotrauma 20 (2003) 59-67
28. Fukiage C., Azuma M., Nakamura Y., et al. SJA6017, a newly synthesized peptide aldehyde inhibitor of calpain: amelioration of cataract in cultured rat lenses. Biochim Biophys Acta 1361 (1997) 304-312
29. Kupina N.C., Nath R., Bernath E.E., et al. The novel calpain inhibitor SJA6017 improves functional outcome after delayed administration in a mouse model of diffuse brain injury. J Neurotrauma 18 (2001) 1229-1240
30. Sharma A.K., and Rohrer B. Calcium-induced calpain mediates apoptosis via caspase-3 in a mouse photoreceptor cell line. J Biol Chem 279 (2004) 35564-35572
31. Allen A.R. Remarks on the histopathological changes in the spinal cord due to impact. An experimental study. J Nerv Ment Dis 41 (1914) 141-147
32. Rivlin A.S., and Tator C.H. Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J Neurosurg 47 (1977) 577-581
33. Tarlov I.M. Spinal Cord Compression: Mechanism of Paralysis and Treatment (1957), Charles C Thomas, Springfield, Illinois
34. Zhivotovsky B., Gahm A., and Orrenius S. Two different proteases are involved in the proteolysis of lamin during apoptosis. Biochem Biophys Res Commun 233 (1997) 96-101
35. Banik N.L., Hogan E.L., Powers J.M., et al. Proteolytic enzymes in experimental spinal cord injury. J Neurol Sci 73 (1986) 245-256
36. Schumacher P.A., Eubanks J.H., and Fehlings M.G. Increased calpain I-mediated proteolysis, and preferential loss of dephosphorylated NF200, following traumatic spinal cord injury. Neuroscience 91 (1999) 733-744
37. Li Z., Hogan E.L., and Banik N.L. Role of calpain in spinal cord injury: increased calpain immunoreactivity in rat spinal cord after impact trauma. Neurochem Res 21 (1996) 441-448
38. Del Bello B., Moretti D., Gamberucci A., et al. Cross-talk between calpain and caspase-3/-7 in cisplatin-induced apoptosis of melanoma cells: a major role of calpain inhibition in cell death protection and p53 status. Oncogene 26 (2007) 2717-2726
39. Ray S.K., Matzelle D.D., Sribnick E.A., et al. Calpain inhibitor prevented apoptosis and maintained transcription of proteolipid protein and myelin basic protein genes in rat spinal cord injury. J Chem Neuroanat 26 (2003) 119-124
40. Ray S.K., Matzelle D.D., Wilford G.G., et al. Increased calpain expression is associated with apoptosis in rat spinal cord injury: calpain inhibitor provides neuroprotection. Neurochem Res 25 (2000) 1191-1198
41. Saito K., Elce J.S., Hamos J.E., et al. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci USA 90 (1993) 2628-2632
42. Young W., Yen V., and Blight A. Extracellular calcium ionic activity in experimental spinal cord contusion. Brain Res 253 (1982) 105-113
43. Tamada Y., Nakajima E., Nakajima T., et al. Proteolysis of neuronal cytoskeletal proteins by calpain contributes to rat retinal cell death induced by hypoxia. Brain Res 19 (2005) 148-155